SharePost Content Read More Yahoo Finance #finance Post navigation BioMarin Shares Jump 5% After Global Patent Settlement With Ascendis Teva’s (TEVA) $125 Million BioXcel Bid Offers Upside, but FDA and Auction Risks Remain